As of November 2024 Aurinia Pharmaceuticals has 143.24M shares outstanding, a increase of 0.93% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 143.24M | 0.93% |
2022 | 141.91M | 9.70% |
2021 | 129.37M | 9.20% |
2020 | 118.47M | - |